Condition: Deep Vein Thrombosis · Pulmonary Embolism · Sponsor: King Abdullah International Medical Research Center
The DETECT randomized controlled trial addresses the question of whether surveillance ultrasound in critically ill patients by facilitating DVT detection reduces the incidence of PE and lowers all-cause 90-day mortality. The primary outcome is 90-day all-cause mortality.
This description comes directly from the study's public registry record.
Yaseen M Arabi · +966118011111 · yaseenarabi@yahoo.com
Haifa Al Humeidi · +966118011111 · alhumediha@mngha.med.sa
Always discuss trial participation with your own doctor first.
| King Abdulaziz Medical City | Riyadh, Riyadh Region, Saudi Arabia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05112705